MonsterSilk™ featured in Textile World edition to be distributed to all Innovation Forum 2014 Attendees

LANSING, Mich., — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced today that the Company’s MonsterSilk™ fiber commercialization ramp up program is the subject of a current article in Textile World.

“It is a huge honor to be featured in this month’s publication of Textile World,” said Kraig CEO and founder, Kim K. Thompson.

“We appreciate the industry exposure for genetically engineered spider silk.  As reported, we are working diligently to expand production and bring our product to commercialization.  Toward that end, our plan is to both expand our production into additional facilities and increase our fiber production at current facilities,” concluded Thompson.

The article can be viewed at the following link; http://www.textileworld.com/Issues/2014/September_October/Quality_Fabric_Of_The_Month/Guided_By_The_Silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

New Testing Advancements to Improve Spider Silk Material Quality and Reduce Variability

LANSING, Mich., –July 30, 2014- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces that research scientists who are working as consultants for the Company have recently implemented a new materials analysis protocol to further improve the quality of the Company’s genetically engineered spider silk based fibers.

The scientists tested the new procedures and are now using them to test individual fiber filaments.  The innovation allows Kraig to gather testing data on its transgenics even before the transgenics reach the stage where they are spinning cocoons.  This early testing data is then incorporated into the decision making process, regarding artificial selection and selective breeding. The new process means the research team can assess, and then make adjustments to variations in, the silk colony, reduce variability, and, the Company believes, further increase the quality of its recombinant fiber production.

“One of the biggest issues we have faced, as we focus on moving our materials to market, is natural variability between individual fiber filaments.  This new protocol and procedure is a significant breakthrough that will allow us to improve quality, while reducing variability. Overcoming this major hurdle has a direct impact in the laboratory and the commercial ramp up program,” said Company founder and CEO, Kim K. Thompson. “I want to thank the scientists who have implemented and are perfecting this protocol, which we believe will have a real impact on our commercialization program.” Thompson concluded.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

LANSING, Mich., July 15, 2014– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces today that “Monster Silk®” is now a registered trademark with the U.S. Patent and Trademark Office.  Monster Silk®, a genetically engineered spider silk fiber, is in the early stages of commercialization.

In addition to Monster Silk®, the U.S. Patent and Trademark Office has registered the Company’s Spiderpillar® and Spilk® trademarks.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Kraig Achieves another Milestone in Spider Silk Commercialization

LANSING, Mich., July 9, 2014— Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced that its Monster Silk™ production program has successfully doubled in size, achieving another major milestone in the Company’s spider silk commercialization process.

“Earlier this year, we set ambitious goals for the growth of our Company and for the production of genetically engineered spider silk,” said Company Founder and CEO, Kim K Thompson “Since then, we have expanded our productive capacity in order to make that growth a reality. The current production run is by far the largest in the Company’s history. The doubling of production is an important milestone in the commercialization of spider silk and is affirmation of the success of our production plan and commercialization strategy,” stated Thompson.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Spider Silk Textile Development Breakthrough

LANSING, Mich., June 18, 2014– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig”), the leading developer of advanced spider silk based fibers, announced today Warwick Mills (“Warwick”), a leader in the engineering and development of advanced technical textiles and protective materials, created the world’s first textile utilizing Kraig’s genetically engineered spider silk, Monster Silk™.

The first Monster Silk™ textiles are knitted gloves and the first photos are available at the following link- https://www.kraiglabs.com/spider-silk-textiles/.  They are considered to be the first of many textiles that are to be created as part of the Company’s joint development agreement with Warwick.

“We have been working with various types of Monster Silk™,” stated Charles Howland, President of Warwick. “We find that all of these fibers are compatible with existing yarn processing and textile formation methods. As is expected, fiber consistency is not yet at full production levels.  However, for the current stage of maturity, these silk materials already have good levels of quality and consistency.  We have been making jersey knit samples and will start weaving shortly.  These small scale trials are key to helping identify, for Kraig Labs, areas for development for upcoming fiber production trials. We are reviewing textile properties of the samples with Kraig staff and exploring the most attractive applications for this fiber.  Overall the trials are well underway and we are making good progress toward commercialization.”

“One of the biggest issues facing our Company was creating our first textile and the open question of whether genetically engineered spider silk could be successfully processed using existing textile formation methods,” said Company founder and CEO, Kim K. Thompson.  “With this successful test, and the creation of the first Monster Silk™ knits, we have established that our genetically engineered spider silk works well with existing manufacturing methods.  The creation of these knits is a huge milestone in our progress toward making genetically engineered spider silk available for industrial and consumer applications. The fact that these advanced materials process well on existing machinery will help speed up the development of advanced spider silk textiles.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Evaluation Team Reports Monster Silk™ Production Ramp Up is Succeeding

LANSING, Mich., May 29, 2014— Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced that its production evaluation team reported that the Company’s genetically engineered spider silk, Monster Silk™, production program is thriving and is successfully accommodating a recent significant increase in the scale of production.

The Company previously reported that its pilot production program’s viable silk cocoon yield rate was at approximately 30%, in late 2013.  By March, after launching the commercial production ramp up program, the yields increased to approximately 70%; more than double the output efficiency from the pilot phase.   The latest report is that with the increased scale of operations in May, the high yields appear to be holding, and possibly improving even further.

The Company believes that the high yield is a result of a combination of improved production procedures and adaptability.  The Company is ordering a further doubling of production in June.

“We always believed that our scientific model would translate very well into real world environments, but to actually see our silkworms perform at this level is inspiring.  The technology is now outperforming the infrastructural capacities, which bodes well for future product, and production, expansion,” said Company Founder and CEO, Kim K. Thompson.

“The fact that the reported yield rates are holding, or improving, has given us the confidence to authorize a doubling of the scale of production. We anticipate this next larger production run will launch in June.  We are excited and encouraged to see that our systems are holding up well as we increase the scale of Monster Silk™ production, and we are working with third parties to strengthen the infrastructure to support the increased production,” Thompson concluded.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Laboratories’ Prepares for First Monster Silk™ Textiles

LANSING, Mich., May 5, 2014– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Kraig”), the leading developer of advanced spider silk based fibers, announced today that Warwick Mills, Inc. (“Warwick”), a leader in the engineering and development of advanced technical textiles and protective materials, is preparing to weave the first textiles with Kraig’s Monster Silk™ recombinant spider silk.  This is part of Kraig’s collaborative development initiative of advanced spider silk based textiles.

Kraig previously shipped Monster Silk™ yarn to Warwick, which after studying the material, requested that it be processed to additional specifications.  The material was shipped back to Kraig and then studied by a silk spinning expert who analyzed the fibers. The fibers were then processed according to the directions and specifications of the spinning expert.  Recently, Kraig received the reprocessed Monster Silk™ and shipped the material to Warwick.  Warwick is now testing and analyzing Kraig’s Monster Silk™ recombinant spider silk and determining the best ply and cord twisting for yarn optimization in preparation for creating sample textiles.

“We appreciate and respect the fact that Warwick asked us to reprocess the material instead of just moving forward at full speed with weaving or knitting,” said Kraig CEO and founder, Kim Thompson. “Warwick has taken the time to do this right.  As a result, the development of Monster Silk™ based textiles is at an exciting stage, Warwick is preparing to create the first Monster Silk™ textiles.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Laboratories Launches New Investor Relations Website

Some Corporate Updates To Be Delivered, in Parallel, Via Social Media

LANSING, Mich., April 28, 2014— Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today invites shareholders, and other followers of the Company’s developments, to visit the new Kraig investor relations website at www.kblbinvestors.com.  The Company is also announcing the launch of social media pages at Facebook and Twitter. The Company may add additional pages at other sites.

“Kraig has been a true trailblazer in applied biotechnology.  As we’ve concentrated on making discoveries in the laboratory, we’ve held off from establishing a social media presence and avoided prematurely incorporating many other public relations tools.  As the Company moves towards commercialization, we’ve achieved a stage in our growth where we can benefit from improved communications. We need to inform industry about what we’ve accomplished, both in the laboratory and in executing our recombinant spider silk commercialization plan,” said Company Founder and CEO, Kim K. Thompson.

“Kraig’s shareholders are one of the keys to our success and these tools should help us keep them informed.  Some of the website content will be designed specifically with our shareholders in mind.

“We view ourselves as the world leader in our exciting field of biotechnology innovation.  As such, we are sensitive to the competitive environment surrounding our inventions and laboratory discoveries.  We will remain guarded on certain details that could give aid to potential competitors, but, as we advance our business model, we plan on revealing additional information in upcoming Company press releases,” Thompson concluded.

The Company intends to distribute information on these sites in compliance with Securities and Exchange Commission’s Regulation Fair Disclosure.  For further Regulation FD information, please go to: http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171513574#.UxdPrc7WBxA.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Laboratories Is Testing Its Big Red™ Genetically Engineered Spider Silk

LANSING, Mich., April 22, 2014— Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that the Company received its fiber testing equipment, including customized components, to test its latest genetically engineered prototype fiber, Big Red™.

The Company announced that it created Big Red™, a new genetically engineered silk fiber, last fall, by using spider silk gene sequences.  Preliminary testing indicated that Big Red™ might have properties of strength and flexibility that could have potential commercial applications.

The Company ordered testing equipment to verify the preliminary results and, after taking delivery, had the equipment customized to account for the unique nature of recombinant spider silk based fibers.

“We are excited to perform a more rigorous evaluation of Big Red™ spider silk with the new equipment. We are hopeful of having definitive test results within the next several weeks.  So far, we are seeing a lot of variability, which may be an indication of genetic variation within the transgenic colony.  Not only will these tests provide us the first comprehensive set of data concerning Big Red™, and potently guide us in improving that transgenic, but it’s also the first major assessment of the new equipment,” said Company founder and CEO, Kim Thompson.

The Company intends to use the testing equipment to increase the laboratory’s research and development effectiveness by providing researchers with more rapid feedback on the results of their work.  The ability to quickly gather and analyze data is expected to greatly improve the effectiveness of the Company’s ongoing work in artificial selection of various strains of transgenic silkworms and potentially reduce the commercialization timeline for future fibers.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com